Medical Xpress on MSN: Targeting protein BCL-2 may create a promising pathway to reversing pulmonary fibrosis Researchers at National Jewish Health and collaborating institutions have uncovered a critical mechanism driving persistent pulmonary fibrosis and identified a promising strategy to reverse it. The ... Targeting protein BCL-2 may create a promising pathway to reversing pulmonary fibrosis AP01 has completed a phase 1b trial (ATLAS) in idiopathic pulmonary fibrosis (IPF) and has started an open-label extension in progressive pulmonary fibrosis (PPF), another form of the disease, as well ...
The Pulmonary Fibrosis Foundation (PFF) today announced its PFF Walk 2026 schedule as the organization celebrates the 10 (th) season of the national fundraising program, which has raised more than $7. Idiopathic pulmonary fibrosis stands as one of medicine’s most challenging respiratory conditions, gradually transforming healthy lung tissue into stiff, scarred material that severely compromises ... Idiopathic pulmonary fibrosis (IPF) is a chronic disease in which healthy lung tissue is gradually replaced by scar tissue. While the early events that initiate this change are poorly understood, ...
fibrosis pulmonar, The American Journal of Managed Care: Identification, Course, and Management of Progressive Pulmonary Fibrosis Medscape: Genetics of Pulmonary Fibrosis: What Is Known and What's to Come?
